Answers are grounded in this paper and cite their sources.
In West Africa, where Human Immunodeficiency Viruses 1 and 2 (HIV-1 and HIV-2) co-circulate, serological assays allowing the reliable serotyping of HIV infection are needed. This study evaluated the performance and described the experience in using a non-commercial peptide-based enzyme immunoassay (PBEIA) in a context of resource-limited setting.
No takes yet. Share an insight, caveat, or question.
Inwoley et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: